Arrowhead Research Corp (ARWR) 16.27 $ARWR
Look for Shares of Arrowhead Research to Potentially Pullback after Yesterday's 6.06% Rise
Comtex SmarTrend(R) - 2 hrs 9 mins ago
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $15.61 to a high of $17.38. Yesterday, the shares gained 6.1%, which took the trading range above the 3-day high of $15.35 on volume of 7.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Nasdaq stocks posting largest percentage increases
AP - Wed Sep 03, 12:34PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
5 Stocks Poised for Big Breakouts
at The Street - Tue Sep 02, 9:48AM CDT
These stocks look ready to break out and trade higher from current levels.
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead
PR Newswire - Fri Aug 29, 7:40AM CDT
Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: BMY) and Arrowhead Research Corp. (NASDAQ: ARWR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6071-100free.
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver
PR Newswire - Wed Aug 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.
Look for Shares of Arrowhead Research to Potentially Pullback after Yesterday's 13.08% Rise
Comtex SmarTrend(R) - Tue Aug 26, 4:06PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $13.90 to a high of $15.57. Yesterday, the shares gained 13.1%, which took the trading range above the 3-day high of $13.61 on volume of 8.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Arrowhead Research (ARWR) Stock Rises on High Volume
at The Street - Tue Aug 26, 1:24PM CDT
Arrowhead Research (ARWR) surged Tuesday after Roche's $8.3 billion acquisition of InterMune (ITMN) led the biotech sector higher.
'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.
Look for Shares of Arrowhead Research to Potentially Rebound after Yesterday's 6.85% Sell Off
Comtex SmarTrend(R) - Thu Aug 21, 5:15PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $12.58 to a high of $13.61. Yesterday, the shares fell 6.8%, which took the trading range below the 3-day low of $13.50 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
5 Stocks Jumping on Unusual Volume
at The Street - Tue Aug 19, 5:30AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
'Mad Money' Lightning Round: Don't Buy IBM Right Now
at The Street - Thu Aug 14, 5:00AM CDT
Cramer says he's avoiding Potbelly but likes Opko Health and Hawaiian Holdings.
Jim Cramer's 'Mad Money' Recap: Now That's More Like It
at The Street - Wed Aug 13, 7:25PM CDT
When the consensus changes, the buyers change, too, and that's why Tuesday's stocks were being bought Wednesday, Cramer says.
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - ZACKS - Wed Aug 13, 2:06AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
SmarTrend Watching for Potential Pullback in Shares of Arrowhead Research After 1.17% Gain
Comtex SmarTrend(R) - Tue Aug 12, 4:14PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $12.70 to a high of $13.71. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $13.50 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Arrowhead Discloses First Human Hepatitis B Therapy Results
at The Street - Tue Aug 12, 4:11PM CDT
The announcement is short on specific details but the Arrowhead drug, ARC-520, appears to have passed through its first clinical hurdle in hepatitis B patients relatively well.
Look for Shares of Arrowhead Research to Potentially Pullback after Yesterday's 6.06% Rise
Comtex SmarTrend(R) - 2 hrs 9 mins ago
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $15.61 to a high of $17.38. Yesterday, the shares gained 6.1%, which took the trading range above the 3-day high of $15.35 on volume of 7.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Nasdaq stocks posting largest percentage increases
AP - Wed Sep 03, 12:34PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
5 Stocks Poised for Big Breakouts
at The Street - Tue Sep 02, 9:48AM CDT
These stocks look ready to break out and trade higher from current levels.
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead
PR Newswire - Fri Aug 29, 7:40AM CDT
Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: BMY) and Arrowhead Research Corp. (NASDAQ: ARWR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6071-100free.
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver
PR Newswire - Wed Aug 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.
Look for Shares of Arrowhead Research to Potentially Pullback after Yesterday's 13.08% Rise
Comtex SmarTrend(R) - Tue Aug 26, 4:06PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $13.90 to a high of $15.57. Yesterday, the shares gained 13.1%, which took the trading range above the 3-day high of $13.61 on volume of 8.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Arrowhead Research (ARWR) Stock Rises on High Volume
at The Street - Tue Aug 26, 1:24PM CDT
Arrowhead Research (ARWR) surged Tuesday after Roche's $8.3 billion acquisition of InterMune (ITMN) led the biotech sector higher.
'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.
Look for Shares of Arrowhead Research to Potentially Rebound after Yesterday's 6.85% Sell Off
Comtex SmarTrend(R) - Thu Aug 21, 5:15PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $12.58 to a high of $13.61. Yesterday, the shares fell 6.8%, which took the trading range below the 3-day low of $13.50 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
5 Stocks Jumping on Unusual Volume
at The Street - Tue Aug 19, 5:30AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
'Mad Money' Lightning Round: Don't Buy IBM Right Now
at The Street - Thu Aug 14, 5:00AM CDT
Cramer says he's avoiding Potbelly but likes Opko Health and Hawaiian Holdings.
Jim Cramer's 'Mad Money' Recap: Now That's More Like It
at The Street - Wed Aug 13, 7:25PM CDT
When the consensus changes, the buyers change, too, and that's why Tuesday's stocks were being bought Wednesday, Cramer says.
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - ZACKS - Wed Aug 13, 2:06AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
SmarTrend Watching for Potential Pullback in Shares of Arrowhead Research After 1.17% Gain
Comtex SmarTrend(R) - Tue Aug 12, 4:14PM CDT
Arrowhead Research (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $12.70 to a high of $13.71. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $13.50 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Arrowhead Discloses First Human Hepatitis B Therapy Results
at The Street - Tue Aug 12, 4:11PM CDT
The announcement is short on specific details but the Arrowhead drug, ARC-520, appears to have passed through its first clinical hurdle in hepatitis B patients relatively well.
